Claim CME Credit View Podcast Archive
Listen to the people behind the science
Northwestern University Feinberg School of Medicine is a research-intensive medical school that fosters powerful collaborations on a thriving academic medical campus. We are driven by our mission to transform the practice of medicine and profoundly impact human health beyond the individual patient. We believe better answers only come from discovery.
Kidneys, COVID-19 and ACE2 Connection with Daniel Batlle, MD
At the beginning of the pandemic, Daniel Batlle, MD, professor
of medicine in the Division of Nephrology-Hypertension at
Northwestern, proposed a hypothesis that soluble ACE2 could treat
the SARS-CoV-2 virus and lead to full recovery and survival. Now,
he has exciting preliminary results to share.
Black Men and Prostate Cancer with Edward Schaeffer, MD, PhD
likely to get
than twice as likely to die from the
disease than other men.
Schaeffer has developed a research team to
this problem. In this show he talks about his latest
paving the way to precision medicine for
prostate cancer. Dr. Schaeffer is the Chair of
of Urology at Northwestern and a Northwestern Medicine urologist
with a specialized practice in prostate cancer.
Northwestern Drug Kills Glioblastoma Tumor Cells with Priya Kumthekar, MD
An early clinical trial in individuals with the deadly brain
cancer glioblastoma showed an experimental spherical nucleic acid
drug developed by Northwestern University scientists was able to
penetrate the blood-brain barrier and trigger the death of tumor
cells. Lead investigator Priya Kumthekar, MD, explains the results
of the study.
Children and COVID-19 Vaccines with William Muller, MD, PhD
COVID-19 vaccines are being doled out across the nation, almost
exclusively to adults. Pfizer's vaccine has been authorized for
ages 16 and up and Moderna's vaccine for 18 and up. So when might
younger children be vaccinated for COVID-19? And what needs to
happen before then? Northwestern's William Muller, MD, PhD, offers
A Promising Obesity Drug with Robert Kushner, MD
The drug semaglutide, typically prescribed for treatment of Type
2 diabetes, was used in a phase 3 clinical trial as a treatment for
obesity with very promising results. Northwestern's Robert Kushner,
MD, led this study, recently published in the New England
Journal of Medicine and shares the results.
Tracking COVID-19 Variants with Ramón Lorenzo Redondo, PhD
Since SARS-CoV-2 was discovered in Illinois over a year ago,
Northwestern scientists have been tracking the evolution of the
disease in the Chicago area. Ramón Lorenzo-Redondo, PhD, research
assistant professor of Medicine in the Division of Infectious
Diseases, is part of the team leading this work. He talks about the
team's research, the new COVID-19 variants and how the vaccines on
the market today stand up to them.
COVID-19 and Vulnerable Communities with Mercedes Carnethon, PhD
Mercedes Carnethon, PhD, a Northwestern Medicine epidemiologist
and a population science expert, talks about how COVID-19 is
affecting Black, Indigenous, Latinx and other people of color the
most, as the pandemic continues and vaccine rollouts lag
Year in Review: How Feinberg Scientists Persevered in 2020 with Erin Spain, MS
In this episode, host Erin Spain takes a look and listen back
on some of
the top Feinberg research published in 2020. Hear how Northwestern
scientists responded to COVID-19 while publishing high-impact
papers unrelated to the pandemic and making vital discoveries
across the research enterprise during a difficult time.
How Lung Transplants Are Saving COVID-19 Patients with Ankit Bharat, MBBS
Ankit Bharat, MBBS, Chief of Thoracic Surgery at Northwestern
Medicine and director of the Lung Transplant program, shares
findings that support why lung transplantation should be considered
for patients who have developed irreversible lung disease due to
Can Exercise Slow Parkinson's Disease Progression? with Daniel Corcos, PhD
A $30 million
trial is about to begin at Northwestern, investigating whether
exercise can slow
Parkinson's disease progression. Daniel
PhD, a professor
of Physical Therapy and Human Movement Sciences is leading the
trial and explains what he hopes to accomplish.
Skilled Surgeons and Colon Cancer Survival with Karl Bilimoria, MD and Brian Brajcich, MD
A new Northwestern Medicine study shows patients whose colon
cancer surgery was performed by a highly skilled surgeon had a 70
percent lower risk of dying over five years compared to patients
with a lower skilled surgeon.
How Amish People Informed a COVID-19 Clinical Trial with Douglas Vaughan, MD
A Swiss Amish community in Indiana has been the focus of ongoing
studies led by Dr. Douglas Vaughan, chair of the Department of
Medicine at Northwestern. Many members of this Amish community have
a gene mutation that appears to protect against biological aging in
a variety of ways. A new experimental drug that effectively
lowers the level of the protein associated with this mutation is
now being tested as a treatment for people with COVID-19, in a
phase 2 clinical trial at Northwestern.
Influenza and COVID-19 with Michael Ison, MD
As flu season begins and COVID-19 continues to spread, Michael
Ison, MD, is here to share some of his latest findings. He is
part of Northwestern research teams running studies on both
COVID-19 and on influenza vaccines and treatments.
At-Home Care for COVID-19 Patients with Jeffrey Linder, MD, MPH
Millions of people are now living with COVID-19 and their long-term
outcomes are unknown. Northwestern's Dr. Jeffrey Linder says more
research studies on this group are needed to provide better
information about COVID-19 care before, during, and beyond the
COVID-19 Antibody Testing with Elizabeth McNally, MD, PhD
A team of Northwestern scientists have come together from across
disciplines to develop a COVID-19 antibody test designed for
at-home use. Elizabeth McNally, MD, PhD, is part of the team
working on this test to determine prior exposure to the virus.
COVID-19 Deaths and Health Racial Disparities with Clyde Yancy, MD
Although COVID-19 doesn't necessarily discriminate, some
communities are far more susceptible to the disease. People who are
black or African-American are more likely to contract the virus -
and to die from it. Clyde Yancy, MD, discusses reasons for these
outcomes and the need to fully address health care disparities in
Wearable Device to Monitor COVID-19 Symptoms with John A. Rogers, PhD
Monitoring patients and frontline health care workers for symptoms
of COVID-19 could get much easier with a small wireless sensor
developed by scientists at Northwestern and the Shirley Ryan
AbilityLab. Northwestern’s John A. Rogers explains.
The Dangers of Unproven COVID-19 Therapies with Benjamin Singer, MD
While the world anxiously awaits a vaccine for COVID-19, some
physicians on the front lines are trying new or repurposed
therapies in an effort to help COVID patients. Dr. Benjamin Singer,
a Northwestern physician-scientist, discusses his experiences in
the ICU during this time and his recently published letter warning
against the use of unproven therapies.
Investigating the New Coronavirus with Karla Satchell, PhD, Part 2
This is an update to the
Jan. 28, 2020 episode about Northwestern's Karla Satchell's
effort to lead an investigation into the structure biology of the
components of COVID-19. The goal is to ultimately understand how to
stop it from replicating in human cells through a medication or
High Risk Adults and COVID-19 with Michael Wolf, PhD, MPH
mid-March, the early days of Chicago's COVID-19 outbreak,
older adults with multiple chronic
conditions didn’t think the disease would affect them and
reported not changing their behaviors, according to the results of
a Northwestern Medicine. Michael Wolf led this study and explains
Staying Positive During Social Isolation with Judith Moskowitz, PhD, MPH
Judith Moskowitz, PhD, MPH, is a social psychologist and
professor of Medical Social Sciences at Feinberg who studies the
impact of positive emotion on health-related and other life stress.
She discusses her research and things you can do to increase
positivity during the COVID-19 pandemic.
Continuing Medical Education Credit
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
Academic/Research, Multiple specialties
At the conclusion of this activity, participants will be able to:
- Identify the research interests and initiatives of Feinberg faculty.
- Discuss new updates in clinical and translational research.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this Enduring Material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claim your creditBack to top